Algo version: 0.98b
StemCell Institute Inc is listed at the JPX Exchange
StemCell Institute Inc [7096.T]
JPX Sector: Healthcare Industry:Biotechnology

Is StemCell Institute Inc stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, StemCell Institute Inc pays dividends. Last time was Friday 29th of November 2024 where the investors holding the stock on Friday 27th of September 2024 were paid JPY25 per share. Over the last 1 times between 2024 and 2024, StemCell Institute Inc has paid JPY25 with an average of JPY25 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for StemCell Institute Inc 10 years ago, but if you had invested on Friday 25th of June 2021 when the price was JPY2 065.00, you would have made a loss of JPY-436.00 per share or -21.11%

Yes, the average daily trading liquidity for StemCell Institute Inc is JPY6 600 thousand. You should therefore be able to get in and out of your positions relatively fast.

StemCell Institute Inc has no real debt, which is good in periods of high inflation. StemCell Institute Inc has a good net profit margin of 16.01% and should have high tolerances against inflation.

We have calculated the inflation risk for StemCell Institute Inc to be low [0.4 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.